Ignite Creation Date:
2024-05-06 @ 7:07 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05909189
Status:
RECRUITING
Last Update Posted:
2023-06-18
First Post:
2023-05-12
Brief Title:
LEADing Dementia End-of-Life Planning Conversations
Sponsor:
University of Utah
Organization:
University of Utah
Study Overview
Official Title:
LEADing Dementia End-of-Life Planning Conversations
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LEAD
Brief Summary:
Advance care planning is important for all adults but perhaps even more so for the 57 million persons with Alzheimers disease or related dementia ADRD due to the progressive and protracted cognitive deterioration associated with the disease process In the context of ADRD medical decision-making at the end of life is typically left to ones care partner who often does not have the knowledge or confidence in their ability to make such decisions This study will refine and evaluate a web-based platform called the LEAD Intervention Life-Planning in Early Alzheimers and other Dementias which is designed to help persons in the preclinical or early stage of ADRD engage in conversations about document and share their end-of-life values and preferences with a care partner extended family members and health care providers
Detailed Description:
Advance care planning is the process that allows individuals to express their future healthcare values and preferences so that these wishes can be enacted in the event that they become incapacitated and unable to participate in their own healthcare decisions In the case of Alzheimers disease or related dementia ADRD the person with dementia care recipient almost inevitably loses decisional capacity toward the end of life given the progressive decline in cognitive functioning that accompanies the disease over time The care partners to persons with dementia most often family members such as spousepartners and adult children are therefore tasked with making end-of-life decisions on behalf of the care recipient with ADRD These care partners are not always well-informed of the care recipients end-of-life values and preferences and therefore may not feel confident in their ability to make decisions regarding care and treatment at the end-of-life resulting in unnecessary futile and often unwanted medical treatments and interventions Oftentimes families do not want to engage in these challenging conversations and wait too long whereby the care recipient with ADRD no longer has the decisional ability to participate in the advance care planning process We developed The LEAD Guide Life-Planning in Early Alzheimers and other Dementias as a tool to help persons with preclinical awareness of ADRD risk and those with early-stage cognitive impairment to begin these important conversations with a care partner In this NIH Stage-1 behavioral intervention study we will refine the LEAD Intervention based on our pilot work Stage 1A and then evaluate the usability acceptability feasibility and initial efficacy of the LEAD Intervention Stage 1B We will recruit a diverse sample of 60 community-dwelling ADRD pairs defined as a care recipient in the preclinical or early stage of ADRD plus their current or anticipated care partner ie spousepartner or adult child Results are expected to show that the LEAD Intervention can improve outcomes related to decision-making self-efficacy through greater advance care planning congruence and improve subjective well-being anxiety and relationship quality as perceived and reported by both the care recipient and the care partner Results from this study have the potential to guide and accelerate the implementation of the LEAD Intervention in community and healthcare practice where a dementia-focused advance care process is needed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 1R01AG069033-01A1 | NIH | None | httpsreporternihgovquickSearch1R01AG069033-01A1 |